Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
We offer shipping options between 1 and 5 days
Phase 2 liver disease data published in Nature Medicine (2024) identifies retatrutide as the compound with the most comprehensive hepatic fat reduction profile currently under clinical investigation, making it the correct peptide for NAFLD and MASH preclinical study designs
Beginners typically start with 0.5-1mg administered subcutaneously 3-5 times per week
This potent antioxidant helps eliminate heavy metals and toxins, supporting liver and kidney function
Does efficacy decline over time (tachyphylaxis)
US$ 24.57
US$ 27.30
US$ 21.98
US$ 26.06
US$ 23.60
